Drug recall

Zyprexa Tablets (Olanzapine), 10 mg., 60-tablet bottles, Rx only, NDC 0002-4117-60, Eli Lilly and Company…

FDA recall event 27157 · Class II · D & K Healthcare Resources, Inc.

Key facts

Event ID 27157
Recall numbers D-338-3, D-339-3, D-340-3, D-341-3
Recalling firm D & K Healthcare Resources, Inc.
Product type Drugs
Products Zyprexa Tablets (Olanzapine), 10 mg., 60-tablet bottles, Rx only, NDC 0002-4117-60, Eli Lilly and Company, Indianapolis, IN. 46825, USA, Zyprexa Tablets (Olanzapine), 15 mg., 60-tablet bottles, Rx only, NDC-0002-4115-60, Eli Lilly and Company, Indianapolis, IN. 46285, USA, Zyprexa Tablets (Olanzapine) 20 mg., 60-tablet bottles, Rx only, Eli Lilly and Company, Indianapolis, IN. 46285, USA, Zyprexa Tablets (Olanzapine), 5 mg., 60-tablet bottles, Rx only, Eli Lilly and Company, Indianapolis, IN. 46285, USA
Classification Class II
Status Ongoing
Voluntary or mandated Firm Initiated
Reason for recall Counterfeit : An unknown number of bottles bearing these lot numbers are counterfeit, in that they have been repackaged, relabeled and/or may contain different strengths or mixed strength tablets…
Initiation date Aug 25, 2003
City Saint Louis
Country United States
FEI number 3004129686

At a glance

  • 1–9 Products in this recall
  • None FDA inspections of this firm (FEI)

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA drug and product recalls

FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.

Source: U.S. Food and Drug Administration (FDA), Enforcement Reports

Browse all FDA drug and product recalls